Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fatima Anjum

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Trials|November 3, 2020
Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trialShaukat Ali, Shobha Luxmi, Fatima Anjum, et al.
Frontiers in Pharmacology|April 9, 2026
Exploring the therapeutic potential of <i>Tetrastigma bracteolatum</i> (Wall.) Planch. methanol extract and its different fractions: <i>in vitro, in vivo,</i> and <i>in silico</i> approachesFatima Anjum Faruquee, Tufael Ahmed, Baudrul Mohammad Shahjalal, et al.
Trials|November 9, 2022
Phase II/III trial of hyperimmune anti-COVID-19 intravenous immunoglobulin (C-IVIG) therapy in severe COVID-19 patients: study protocol for a randomized controlled trialShaukat Ali, Elisha Shalim, Farah Farhan, et al.
Eclinicalmedicine|June 10, 2021
Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trialShaukat Ali, Syed Muneeb Uddin, Elisha Shalim, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 1, 2025
Trajectories of FEV<sub>1</sub> after lung transplantation and patient outcomesMarc Raynaud, Natalia Belousova, Matthieu Glorion, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Trials|November 3, 2020
Hyperimmune anti-COVID-19 IVIG (C-IVIG) Therapy for Passive Immunization of Severe and Critically Ill COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trialShaukat Ali, Shobha Luxmi, Fatima Anjum, et al.
Frontiers in Pharmacology|April 9, 2026
Exploring the therapeutic potential of <i>Tetrastigma bracteolatum</i> (Wall.) Planch. methanol extract and its different fractions: <i>in vitro, in vivo,</i> and <i>in silico</i> approachesFatima Anjum Faruquee, Tufael Ahmed, Baudrul Mohammad Shahjalal, et al.
Trials|November 9, 2022
Phase II/III trial of hyperimmune anti-COVID-19 intravenous immunoglobulin (C-IVIG) therapy in severe COVID-19 patients: study protocol for a randomized controlled trialShaukat Ali, Elisha Shalim, Farah Farhan, et al.
Eclinicalmedicine|June 10, 2021
Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trialShaukat Ali, Syed Muneeb Uddin, Elisha Shalim, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 1, 2025
Trajectories of FEV<sub>1</sub> after lung transplantation and patient outcomesMarc Raynaud, Natalia Belousova, Matthieu Glorion, et al.
Pageof 4